Sanne de Bruin

218 Chapter 9 References 1. Carson, J. L. et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA 316 , 2025–2035 (2016). 2. National Institute for Health and Care Excellence. Blood Transfusion . Blood Transfusion (2015). 3. Vlaar, A. P. et al. Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive CareMedicine. Intensive CareMed. (2020). doi:10.1007/s00134- 019-05884-8 4. Ducrocq, G. et al. Effect of a Restrictive vs Liberal Blood Transfusion Strategy onMajor Cardiovascular Events among Patients with Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. JAMA - J. Am. Med. Assoc. 325 , 552–560 (2021). 5. Weiskopf, R. B. et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279 , 217–21 (1998). 6. Vlaar, A. P. J. et al. Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. (2021). doi:10.1007/s00134- 021-06531-x 7. Curley, A. et al. Randomized Trial of Platelet-Transfusion Thresholds in Neonates. N. Engl. J. Med. 380 , 242–251 (2019). 8. Baharoglu, M. I. et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associatedwith antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387 , 2605–2613 (2016). 9. van deWeerdt, E. K. et al. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial. Trials 19 , 127 (2018). 10. Müller, M. C. et al. Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion 55 , 26–35; quiz 25 (2015). 11. Carson, J. L. et al. Plasma trial: Pilot randomized clinical trial to determine safety and efficacy of plasma transfusions. Transfusion 2025–2034 (2021). doi:10.1111/trf.16508 12. Schofield, W. N., Rubin, G. L. & Dean, M. G. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med. J. Aust. 178 , 117–121 (2003). 13. Tinmouth, A. et al. Utilization of frozen plasma in Ontario: A provincewide audit reveals a high rate of inappropriate transfusions. Transfusion 53 , 2222–2229 (2013). 14. Damiani, G. et al. Appropriateness of fresh-frozen plasma usage in hospital settings: Ameta-analysis of the impact of organizational interventions. Transfusion 50 , 139–144 (2010). 15. Heaton, W. A. Evaluation of posttransfusion recovery and survival of transfused red cells. Transfus. Med. Rev. 6 , 153–69 (1992). 16. Sakka, S. G., Reinhart, K. &Meier-Hellmann, A. Comparison of invasive and noninvasivemeasurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med. 26 , 1553–1556 (2000). 17. Anthony, M. Y., Goodall, S. R., Papouli, M. & Levene, M. I. Measurement of plasma volume in neonates. Arch. Dis. Child. 67 , 36–40 (1992).